Kuikui Jiang

587 total citations
30 papers, 227 citations indexed

About

Kuikui Jiang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kuikui Jiang has authored 30 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kuikui Jiang's work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (6 papers). Kuikui Jiang is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (6 papers). Kuikui Jiang collaborates with scholars based in China. Kuikui Jiang's co-authors include Ruoxi Hong, Fei Xu, Qianyi Lu, Shusen Wang, Zhongxi Huang, Jiahong Wang, Lingfeng Zhao, Ziying Zhou, Hua‐Feng Wang and Wen Xia and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Annals of Oncology.

In The Last Decade

Kuikui Jiang

26 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuikui Jiang China 9 96 81 73 51 26 30 227
Aya El Helali Hong Kong 9 108 1.1× 94 1.2× 53 0.7× 59 1.2× 22 0.8× 34 288
Carol Farhangfar United States 6 67 0.7× 71 0.9× 82 1.1× 65 1.3× 15 0.6× 21 202
Jian Yue China 10 127 1.3× 132 1.6× 106 1.5× 63 1.2× 14 0.5× 47 337
Xuhui Guo China 10 130 1.4× 188 2.3× 93 1.3× 54 1.1× 19 0.7× 26 311
Samira Kamrudin United States 3 156 1.6× 63 0.8× 124 1.7× 48 0.9× 29 1.1× 6 278
Xiaohong Xu China 9 73 0.8× 121 1.5× 72 1.0× 59 1.2× 35 1.3× 27 268
Francesca Holt United Kingdom 4 73 0.8× 53 0.7× 82 1.1× 50 1.0× 23 0.9× 6 204
Michael Leisch Austria 9 72 0.8× 115 1.4× 56 0.8× 22 0.4× 14 0.5× 14 273
Mingwen Huang China 10 87 0.9× 142 1.8× 74 1.0× 54 1.1× 13 0.5× 22 279
Mark D. McKee United States 7 137 1.4× 80 1.0× 107 1.5× 39 0.8× 15 0.6× 9 259

Countries citing papers authored by Kuikui Jiang

Since Specialization
Citations

This map shows the geographic impact of Kuikui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuikui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuikui Jiang more than expected).

Fields of papers citing papers by Kuikui Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuikui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuikui Jiang. The network helps show where Kuikui Jiang may publish in the future.

Co-authorship network of co-authors of Kuikui Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Kuikui Jiang. A scholar is included among the top collaborators of Kuikui Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuikui Jiang. Kuikui Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Qianyi, Jianwei Zhang, Limin Chen, et al.. (2024). Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer. The Breast. 76. 103760–103760. 1 indexed citations
2.
Yin, Lei, Chunyu Cao, Kai Zhang, et al.. (2024). Fragmentomics of cell-free DNA as a sensitive biomarker for early detection of pancreatic cancer. HPB. 26. S120–S121.
3.
Xu, Fei, Yongkui Lu, Caiwen Du, et al.. (2024). Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis. npj Breast Cancer. 10(1). 45–45. 3 indexed citations
4.
Lu, Qianyi, Na Wang, Kuikui Jiang, et al.. (2024). Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population. ESMO Open. 9(3). 102389–102389. 3 indexed citations
5.
Wang, Liye, Peng Sun, Qiufan Zheng, et al.. (2023). Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis. Cancer Medicine. 13(1). e6896–e6896. 1 indexed citations
6.
Li, Mei, Qianyi Lu, Jia Fu, et al.. (2023). The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer. npj Breast Cancer. 9(1). 30–30.
7.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2023). Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of Personalized Medicine. 13(2). 365–365.
8.
9.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2023). Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study. Cancer Research and Treatment. 56(2). 513–521. 2 indexed citations
10.
Hong, Ruoxi, Wen Xia, Liye Wang, et al.. (2021). Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study. Cancer Communications. 41(2). 171–182. 23 indexed citations
11.
Wang, Liye, Qianyi Lu, Kuikui Jiang, et al.. (2021). BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review. Oncology Research and Treatment. 45(1-2). 54–61. 13 indexed citations
12.
13.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2021). Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer. Frontiers in Oncology. 11. 747012–747012. 4 indexed citations
14.
Wu, Ying, et al.. (2021). Identification of a risk prediction model for clinical prognosis in HER2 positive breast cancer patients. Genomics. 113(6). 4088–4097. 8 indexed citations
15.
Lu, Qianyi, Fei Xu, Wen Xia, et al.. (2020). Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center. Cancer Communications. 40(5). 222–233. 15 indexed citations
16.
17.
Jiang, Kuikui, Wen Xia, Ruoxi Hong, et al.. (2020). Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy. Translational Cancer Research. 9(2). 1225–1234. 3 indexed citations
18.
Zhang, Kai, Kuikui Jiang, Ruoxi Hong, et al.. (2020). Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer. PeerJ. 8. e10468–e10468. 15 indexed citations
19.
Xu, Fei, Wen Xia, Hai Liao, et al.. (2020). Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study. The Oncologist. 25(9). e1286–e1291. 3 indexed citations
20.
Xue, Cong, Wenwen Wei, Peng Sun, et al.. (2018). Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment. 173(3). 619–628. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aya El Helali Breakdown of academic impact, for papers by Carol Farhangfar Breakdown of academic impact, for papers by Jian Yue Breakdown of academic impact, for papers by Xuhui Guo Breakdown of academic impact, for papers by Samira Kamrudin Breakdown of academic impact, for papers by Xiaohong Xu Breakdown of academic impact, for papers by Francesca Holt Breakdown of academic impact, for papers by Michael Leisch Breakdown of academic impact, for papers by Mingwen Huang Breakdown of academic impact, for papers by Mark D. McKee
Rankless by CCL
2026